In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...
News-Medical.Net on MSN
Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
MedPage Today on MSN
Bubbles of prostate cancer info; cancer drug tops moneymakers; small kidney tumors
News, features, and commentary about cancer-related issues ...
Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...
The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...
Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.
Roquefort Therapeutics is acquiring exclusive worldwide rights to a clinical-stage tumour inhibitor for £32m in an all-paper ...
Bayer sued rival Johnson & Johnson for launching a “false advertising campaign” based on flawed data to wrongfully promote ...
By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results